Acomprehensive program that prepares adults and teenagers for a variety of post-secondary options including community or career college biotechnology certificate programs, four-year biotechnology degree programs, and industry workplaces. The vast
Acomprehensive program that prepares adults and teenagers for a variety of post-secondary options including community or career college biotechnology certificate programs, four-year biotechnology degree programs, and industry workplaces. The vast
Myeloperoxidase (MPO), released from neutrophils to degrade invading pathogens, provides one of the earliest lines of defense in innate immunity. It catalyzes the hydrogen peroxide-mediated oxidation of halide ions to products such as hypochlorous
Myeloperoxidase (MPO), released from neutrophils to degrade invading pathogens, provides one of the earliest lines of defense in innate immunity. It catalyzes the hydrogen peroxide-mediated oxidation of halide ions to products such as hypochlorous
A reversible acetylcholinesterase inhibitor that readily crosses the blood-brain barrier to reduce the breakdown of acetylcholine commonly used in the treatment of Alzheimer&rsquos disease to improve cognition, memory, and behavior.
A reversible acetylcholinesterase inhibitor that readily crosses the blood-brain barrier to reduce the breakdown of acetylcholine commonly used in the treatment of Alzheimer&rsquos disease to improve cognition, memory, and behavior.
A selective RAR&beta and RAR&gamma antagonist (Kds = 110, 306, and > 2,250 nM for RAR&gamma, RAR&beta, and RAR&alpha, respectively, with no binding at RXR&alpha).
A selective RAR&beta and RAR&gamma antagonist (Kds = 110, 306, and > 2,250 nM for RAR&gamma, RAR&beta, and RAR&alpha, respectively, with no binding at RXR&alpha).
A non-chlorinated analog of OTA that has cytotoxic effects on kidney and liver cells in vitro but only minor effects in vivo, due to its rapid metabolism and excretion inhibits cell proliferation of human liver HepG2 cells at doses as low as 1
A non-chlorinated analog of OTA that has cytotoxic effects on kidney and liver cells in vitro but only minor effects in vivo, due to its rapid metabolism and excretion inhibits cell proliferation of human liver HepG2 cells at doses as low as 1
A selective inhibitor of NUAK1 (IC<sub>50</sub> = 100 nM) partially inhibits the phosphorylation of the NUAK1 substrate MYPT1 at Ser445 inhibits proliferation and migration of mouse embryonic fibroblasts and U2OS cells at 10 µM in cell-based
A selective inhibitor of NUAK1 (IC<sub>50</sub> = 100 nM) partially inhibits the phosphorylation of the NUAK1 substrate MYPT1 at Ser445 inhibits proliferation and migration of mouse embryonic fibroblasts and U2OS cells at 10 µM in cell-based
HQL-79 is a selective inhibitor of hematopoietic PGD synthase. Structurally, it is a synthetic tetrazole compound originally prepared as a possible antihistamine.
HQL-79 is a selective inhibitor of hematopoietic PGD synthase. Structurally, it is a synthetic tetrazole compound originally prepared as a possible antihistamine.
A selective inhibitor of NUAK1 (IC<sub>50</sub> = 100 nM) partially inhibits the phosphorylation of the NUAK1 substrate MYPT1 at Ser445 inhibits proliferation and migration of mouse embryonic fibroblasts and U2OS cells at 10 µM in cell-based
A selective inhibitor of NUAK1 (IC<sub>50</sub> = 100 nM) partially inhibits the phosphorylation of the NUAK1 substrate MYPT1 at Ser445 inhibits proliferation and migration of mouse embryonic fibroblasts and U2OS cells at 10 µM in cell-based